Frank Karbe

Affiliations

  • Insider at Phathom Pharmaceuticals Inc. (PHAT), 2025-06-05
  • Chief Financial Officer at Cidara Therapeutics Inc. (CDTX), 2025-02-26
  • Chief Executive Officer at Better Therapeutics Inc. (BTTX), 2023-12-20
  • Principal Fin'l & Accounting at Myovant Sciences Ltd. (MYOV), 2021-07-09
  • Director at Aduro Biotech Inc. (ADRO), 2020-05-29
  • Director at Arbutus Biopharma Corp (ABUS), 2017-06-23
  • Evp And Cfo at Exelixis Inc. (EXEL), 2014-02-19
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PHAT $7.93 12,500 $99,083.75 57,000 2024-12-13 Filing
BTTX $0.73 137,005 $99,999.95 429,429 2023-07-27 Filing
BTTX $0.83 242,424 $199,999.80 292,424 2023-04-10 Filing
BTTX $2.09 50,000 $104,695.00 50,000 2022-09-15 Filing
MYOV $9.10 8,000 $72,800.00 8,000 2019-06-11 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MYOV $21.75 3,232 $70,296.00 212,296 2021-07-07 Filing
MYOV $18.63 11,080 $206,420.40 152,390 2021-04-06 Filing
MYOV $21.40 750 $16,050.00 163,470 2021-02-16 Filing
MYOV $24.00 300 $7,200.00 163,470 2021-01-28 Filing
MYOV $21.50 750 $16,125.00 163,470 2021-01-15 Filing